Kern Pharma, a CataloniaBio member company, has acquired Spanish self-care pharmaceutical company Actafarma. This operation comes under the business diversification strategy for growth in Kern Pharma, which is based in Terrassa (Barcelona). “By acquiring Actafarma, we are strengthening our self-care line, as the company already has a wide range of consolidated products like Oxicol and others with great potential that have been recently launched to market,” explains CEO Raúl Díaz-Varela.

Laboratoris Actafarma was established in 1997 in Alcorcón (Madrid). In 2016, the company posted revenue of €10 million and it currently has a staff of 60 employees. 

More information is available on the Kern Pharma website.